NO963052D0 - Process for solubilizing poorly soluble pharmaceutically active components - Google Patents

Process for solubilizing poorly soluble pharmaceutically active components

Info

Publication number
NO963052D0
NO963052D0 NO963052A NO963052A NO963052D0 NO 963052 D0 NO963052 D0 NO 963052D0 NO 963052 A NO963052 A NO 963052A NO 963052 A NO963052 A NO 963052A NO 963052 D0 NO963052 D0 NO 963052D0
Authority
NO
Norway
Prior art keywords
pharmaceutically active
active components
poorly soluble
soluble pharmaceutically
solubilizing poorly
Prior art date
Application number
NO963052A
Other languages
Norwegian (no)
Other versions
NO963052L (en
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO963052D0 publication Critical patent/NO963052D0/en
Publication of NO963052L publication Critical patent/NO963052L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO963052A 1994-01-24 1996-07-22 Process for solubilizing poorly soluble pharmaceutically active components NO963052L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (2)

Publication Number Publication Date
NO963052D0 true NO963052D0 (en) 1996-07-22
NO963052L NO963052L (en) 1996-09-24

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963052A NO963052L (en) 1994-01-24 1996-07-22 Process for solubilizing poorly soluble pharmaceutically active components

Country Status (14)

Country Link
EP (1) EP0741560A1 (en)
JP (1) JPH09508128A (en)
CN (1) CN1138827A (en)
AU (1) AU706890B2 (en)
BR (1) BR9506564A (en)
CA (1) CA2181241C (en)
CZ (1) CZ210496A3 (en)
FI (1) FI962948A0 (en)
MX (1) MX9602955A (en)
NO (1) NO963052L (en)
NZ (1) NZ279443A (en)
PL (1) PL315635A1 (en)
SK (1) SK96196A3 (en)
WO (1) WO1995019759A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
CA2318128C (en) 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (en) * 1999-07-29 2003-05-09 So Ge Val Sa CONCENTRATED AND STABILIZED ANTIPYRETIC COMPOSITION FOR VETERINARY USE INTENDED TO BE INCORPORATED IN ANIMAL FEEDING AS WELL AS A METHOD OF INCORPORATING THIS COMPOSITION INTO ANIMAL BEVERAGE WATER
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (en) * 2000-03-07 2001-09-13 Bayer Ag Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster
KR20020069387A (en) * 2001-02-26 2002-09-04 진양제약주식회사 Mixing method of composition containing doxylamine succinate and soft capsule preparation containing the composition
MXPA04001026A (en) * 2001-07-31 2005-06-20 Wyeth Corp Sucralose formulations to mask unpleasant tastes.
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (en) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets
CN101360485B (en) * 2005-10-26 2013-04-17 班纳制药公司 Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (en) 2005-11-04 2007-05-10 Basf Ag Use of copolymers as solubilizers for sparingly water-soluble compounds
JP2009523119A (en) * 2005-12-09 2009-06-18 ビーエーエスエフ ソシエタス・ヨーロピア Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilizers for compounds that are poorly soluble in water
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (en) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd Soft capsule
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
HUE054836T2 (en) * 2010-01-28 2021-10-28 Eagle Pharmaceuticals Inc Formulations of bendamustine
CA2867343C (en) 2012-03-20 2020-08-11 Eagle Pharmaceuticals, Inc. Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
WO2013142358A1 (en) 2012-03-20 2013-09-26 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
CN105007891B (en) * 2013-02-28 2018-01-16 辉瑞公司 The stability of the enhancing of new liq composition
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (en) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 Method of preparing very slightly soluble drug with solid dosage form
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
SK96196A3 (en) 1997-03-05
AU706890B2 (en) 1999-07-01
AU1607595A (en) 1995-08-08
JPH09508128A (en) 1997-08-19
FI962948A (en) 1996-07-23
PL315635A1 (en) 1996-11-25
CZ210496A3 (en) 1996-12-11
NO963052L (en) 1996-09-24
BR9506564A (en) 1997-09-02
EP0741560A1 (en) 1996-11-13
CN1138827A (en) 1996-12-25
CA2181241A1 (en) 1995-07-27
MX9602955A (en) 1997-06-28
FI962948A0 (en) 1996-07-23
WO1995019759A1 (en) 1995-07-27
NZ279443A (en) 1998-04-27
CA2181241C (en) 2000-04-25

Similar Documents

Publication Publication Date Title
NO963052D0 (en) Process for solubilizing poorly soluble pharmaceutically active components
PL326353A1 (en) Pharmaceutically active quinozolinic compounds
EE9800298A (en) Pharmaceutically useful compounds
NO950134D0 (en) Formulations for orally administered pharmaceutical agents
DE69528843D1 (en) PHARMACOLOGICALLY ACTIVE 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES
GB9526511D0 (en) Pharmaceutically active compounds
HU9602009D0 (en) Process for solubilizing difficultly soluble pharmaceutical actives
KR970054136U (en) Footrests for vans
ES1030931Y (en) PERFECTED BED SUPPORT.
GB9502229D0 (en) Pharmaceutically active compounds
GB9513775D0 (en) Pharmaceutically active compounds
GB9510461D0 (en) Pharmaceutically active compounds
GB9509942D0 (en) Pharmaceutically active compounds
GB9507641D0 (en) Pharmaceutically active compounds
GB9505677D0 (en) Pharmaceutically active compounds
GB9505076D0 (en) Pharmaceutically active compounds
GB9502670D0 (en) Pharmaceutically active compounds
GB9502669D0 (en) Pharmaceutically active compounds
GB9502668D0 (en) Pharmaceutically active compounds
GB9502541D0 (en) Pharmaceutically active compounds
GB9502429D0 (en) Pharmaceutically active compounds
GB9506274D0 (en) Pharmaceutically active compounds
GB9501122D0 (en) Pharmaceutically active compounds
GB9500427D0 (en) Pharmaceutically active compounds
GB9500099D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application